SCHEMBL6745937

SCHEMBL6745937

c1ccc(-c2c(-c3ccc(-c4ccccn4)nc3)sc(-c3cccc(-c4ccccn4)n3)c2-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
LMNA P02545 4/20 0.49
TP53 P04637 4/20 0.49
HTT P42858 4/20 0.49
CCR1 P32246 3/20 0.49
CCR5 P51681 3/20 0.49
CCR8 P51685 3/20 0.49
ALOX15 P16050 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALPL P05186 1/20 0.49
HSP90AA1 P07900 1/20 0.49
ALPI P09923 1/20 0.49
ALPG P10696 1/20 0.49
MAPK1 P28482 1/20 0.49
HPGDS O60760 1/20 0.46
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743821 0.92 HPGDS (0.52) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL4949169 0.90 KDM4E (0.60) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL6745964 0.86 RAB9A (0.41) KDM4ESMN1; SMN2LMNATP53TDP1
SCHEMBL6744236 0.84 KDM4E (0.50) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL6747696 0.81 KDM4E (0.69) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL6744671 0.79 KDM4E (0.46) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL6654002 0.79 KDM4E (0.52) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL20885132 0.79 KDM4E (0.72) KDM4ESMN1; SMN2LMNATP53HTT
SCHEMBL6742138 0.79 RAB9A (0.48) KDM4ESMN1; SMN2LMNATP53TDP1
SCHEMBL6747686 0.78 KDM4E (0.45) KDM4ESMN1; SMN2LMNATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696182-B2 HIGH PERFORMANCE DIPYRIDYL THIOPHENE OR DIPYRIDYL THIOPHENE DIOXIDE ELECTRON TRANSPORT MATERIALS WHICH WHEN EMPLOYED CAN GIVE LOW-VOLTAGE, HIGH EFFICIENCY ORGANIC ELECTROLUMINESCENT DEVICES CHISSO CORPORATION (JP) 2004-02-24 US disclosed
EP-1186605-B1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORP (JP) 2003-04-16 EP disclosed
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-21 US disclosed
EP-1186605-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative LAGE3, MAL2, ELF3 KDM4E 276/4885SMN1; SMN2 3318/4885LMNA 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.